ABIO To Start Phase 2 COVID-19 Trial In Q4, ACIU On Track, BCLI Expects ALS Trial Data In Nov.

Today's Daily Dose brings you news about ARCA biopharma's progress in its COVID-19 drug candidate, AC Immune' upcoming milestones, BrainStorm Cell's November catalyst, Bristol-Myers/Pfizer's Eliquis patent suit ruling, and Novavax's positive phase I data from its COVID-19 vaccine trial.

from RTT - Biotech https://ift.tt/2DzYRg6
via IFTTT